CytoVale

South San Francisco, CA · Founded 2013 · Privately Held (backing)

Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning. CytoVale is based in South San Francisco, CA and was founded in 2013. Its last known valuation is $340 million. It has raised $228 million across 3 recorded rounds; the latest was a $16.4 million debt round in Dec 2020.

Last price · $/share
—
Implied valuation
$340.0M
Total raised
$228.2M
Last round
Debt
Dec 2020

Who backs CytoVale?

35 investors
InvestorType
Alumni VenturesVenture capital
US National Science FoundationOther
Google for StartupsOther
National Institutes of HealthOther
Western Technology InvestmentVenture capital
NorwestVenture capital
University of CaliforniaOther
Baidu VenturesOther
CPP InvestmentsOther
Sands CapitalGrowth equity
+ 25 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CytoVale investors

35 investors are on record for CytoVale, including Alumni Ventures, US National Science Foundation, Google for Startups and National Institutes of Health. By type, the record holds 5 venture capital firms and 1 growth equity firm. The debt round in Dec 2020 drew 23 investors.

Free account
More of CytoVale with a free account
  • ·The complete investor list: 35 names
  • ·Watch CytoVale: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 35 firms already write checks for companies like CytoVale. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View